Research article
Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
- Equal contributors
1 Department of Internal Medicine, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun–gu, Seoul 120-752, Korea
2 Department of Radiology, Yonsei University College of Medicine, Seoul, Korea
3 Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea
4 Liver Cirrhosis Clinical Research Center, Seoul, Korea
5 Brain Korea 21 Project for Medical Science, Seoul, Korea
BMC Cancer 2013, 13:5 doi:10.1186/1471-2407-13-5
Published: 3 January 2013Additional files
Additional file 1:
Table S1. Independent predictors between cTM responder with Radiologic non-responder ( n = 8 ) and cTM non-responder with radiologic responder ( n = 12 ). Figure S1. Progression-free survival (PFS) and overall survival (OS) curves of TM responder with radiologic non-responder and TM non-responder with radiologic non-responder. Both PFS and OS were not significantly different between TM responder with radiologic non-responder and TM non-responder with radiologic non-responder (5.1 vs. 5.1 months; log rank test, P=0.828 for PFS (A) and 33.8 vs. 7.5 months; log rank test, P=0.354 for OS (B)). Figure S2. Progression-free survival (PFS) and overall survival (OS) curves of cTM responder with radiologic responder and cTM non-responder with radiologic non-responder. PFS was similar between cTM responder with radiologic responder and cTM non-responder with radiologic non-responder (19.0 vs. 6.2 months; log rank test, P=0.065 for PFS (A)) whereas OS were significantly better in cTM responder with radiologic responder than cTM non-responder with radiologic non-responder (39.2 vs. 12.8 months; log rank test, P=0.031 for OS (B)).
Format: DOCX Size: 244KB Download file


